Tag Germany

Study Data from University Hospital Provide New Insights into Gastroenterology

Dec31

By a News Reporter-Staff News Editor at Gastroenterology Week Data detailed on Gastroenterology have been presented. According to news originating from Aachen, Germany, by NewsRx correspondents, research stated, "Only few case studies address pseudo-obstruction, a disorder -which often frustrates clinicians and patients due to an unclear diagnosis and limited therapeutic options. Thus, the aim of […]

New Cardiovascular Research Research Has Been Reported by Scientists at University Hospital

Dec31

By a News Reporter-Staff News Editor at Cardiovascular Week Current study results on Cardiovascular Research have been published. According to news reporting originating from Kiel, Germany, by NewsRx correspondents, research stated, "The aim of our prospective study was to investigate the applicability and the diagnostic value of near-infrared spectroscopy (NIRS) in SAH patients using the […]

Special Report: The Pricing and Reimbursement Environment for Autoimmune Biologics

Sep28

Research and Markets has announced the addition of Decision Resources, Inc.’s new report "Special Report: The Pricing and Reimbursement Environment for Autoimmune Biologics" to their offering (see also Arthritis).The combined diagnosed populations of patients with Crohn’s disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, systemic lupus erythematosus (SLE), and ulcerative colitis in seven leading pharmaceutical markets (United […]

Research and Markets Adds Report: Special Report: The Pricing and Reimbursement Environment for Autoimmune Biologics [Manufacturing Close

Sep21

Research and Markets has announced the addition of Decision Resources, Inc.’s new report "Special Report: The Pricing and Reimbursement Environment for Autoimmune Biologics" to its offerings.In a release, Research and Markets noted that report highlights include:The combined diagnosed populations of patients with Crohn’s disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, systemic lupus erythematosus, and ulcerative colitis […]

AP Business NewsBrief at 5:44 p.m. EDT

Sep14

Stocks jump on hopes for progress on Greece’s debtNEW YORK (AP) – A promise by European leaders to help Greece avoid default sent stocks sharply higher Wednesday, the third day of gains in a row. The leaders of Greece, France and Germany agreed in a teleconference that Greece was an "integral" part of the 17-country […]

AP Business NewsBrief at 5:47 p.m. EDT

Sep14

Stocks jump on hopes for progress on Greece’s debtNEW YORK (AP) – A promise by European leaders to help Greece avoid default sent stocks sharply higher Wednesday for the third straight day. The leaders of Greece, France and Germany agreed in a teleconference that Greece was an "integral" part of the 17-country bloc that uses […]

AP Business NewsBrief at 5:55 p.m. EDT

Sep14

Stocks jump on hopes for progress on Greece’s debtNEW YORK (AP) – A promise by European leaders to help Greece avoid default sent stocks sharply higher Wednesday for the third straight day. The leaders of Greece, France and Germany agreed in a teleconference that Greece was an "integral" part of the 17-country bloc that uses […]

AP Business NewsBrief at 6:08 p.m. EDT

Sep14

Stocks jump on hopes for progress on Greece’s debtNEW YORK (AP) – A promise by European leaders to help Greece avoid default sent stocks sharply higher Wednesday for the third straight day. The leaders of Greece, France and Germany agreed in a teleconference that Greece was an "integral" part of the 17-country bloc that uses […]

AP Business NewsBrief at 6:09 p.m. EDT

Sep14

Stocks jump on hopes for progress on Greece’s debtNEW YORK (AP) – A promise by European leaders to help Greece avoid default sent stocks sharply higher Wednesday for the third straight day. The leaders of Greece, France and Germany agreed in a teleconference that Greece was an "integral" part of the 17-country bloc that uses […]

Research and Markets: Special Report: The Pricing and Reimbursement Environment for Autoimmune Biologics

Sep14

DUBLIN(BUSINESS WIRE) Research and Markets has announced the addition of Decision Resources, Inc.’s new report “Special Report: The Pricing and Reimbursement Environment for Autoimmune Biologics” to their offering. The combined diagnosed populations of patients with Crohn’s disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, systemic lupus erythematosus (SLE), and ulcerative colitis in seven leading pharmaceutical markets (United […]